Kurata Lance's most recent trade in Arcturus Therapeutics Holdings Inc was a trade of 54,000 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Dec. 17, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Arcturus Therapeutics Holdings Inc | Lance Kurata | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 54,000 | 54,000 | - | - | Employee Stock Option (right to buy) | |
| Arcturus Therapeutics Holdings Inc | Lance Kurata | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2024 | 60,000 | 60,000 | - | - | Employee Stock Option (right to buy) | |
| Arcturus Therapeutics Holdings Inc | Kurata Lance | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2023 | 75,000 | 75,000 | - | - | Employee Stock Option (right to buy) | |
| Arcturus Therapeutics Holdings Inc | Lance Kurata | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2022 | 125,000 | 125,000 | - | - | Employee Stock Option (right to buy) | |
| Arcturus Therapeutics Holdings Inc | Lance Kurata | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 50,000 | 50,000 | - | - | Employee Stock Option (right to buy) |